{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T21:20:30Z","timestamp":1792790430067,"version":"4.5.0"},"reference-count":36,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2012,1,1]],"date-time":"2012-01-01T00:00:00Z","timestamp":1325376000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,1,1]],"date-time":"2012-01-01T00:00:00Z","timestamp":1325376000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journalofinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection"],"published-print":{"date-parts":[[2012,1]]},"DOI":"10.1016\/j.jinf.2011.11.002","type":"journal-article","created":{"date-parts":[[2011,11,11]],"date-time":"2011-11-11T22:56:22Z","timestamp":1321052182000},"page":"68-75","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":135,"title":["Rare opportunistic (non-Candida, non-Cryptococcus) yeast bloodstream infections in patients with cancer"],"prefix":"10.1016","volume":"64","author":[{"given":"Maria N.","family":"Chitasombat","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diamantis P.","family":"Kofteridis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey","family":"Tarrand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Russell E.","family":"Lewis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitrios P.","family":"Kontoyiannis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jinf.2011.11.002_bib1","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1080\/00365540410017563","article-title":"Trichosporonosis in a tertiary care cancer center: risk factors, changing spectrum and determinants of outcome","volume":"36","author":"Kontoyiannis","year":"2004","journal-title":"Scand J Infect Dis"},{"key":"10.1016\/j.jinf.2011.11.002_bib2","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/S1473-3099(10)70218-8","article-title":"Emerging opportunistic yeast infections","volume":"11","author":"Miceli","year":"2011","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.jinf.2011.11.002_bib3","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1086\/341305","article-title":"Breakthrough trichosporonosis in a bone marrow transplant recipient receiving caspofungin acetate","volume":"35","author":"Goodman","year":"2002","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jinf.2011.11.002_bib4","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1086\/500323","article-title":"Breakthrough trichosporonosis in patients with hematologic malignancies receiving micafungin","volume":"42","author":"Matsue","year":"2006","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jinf.2011.11.002_bib5","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1111\/j.1399-3062.2009.00418.x","article-title":"Disseminated Geotrichum candidum infection in a patient with relapsed acute myelogenous leukemia following allogeneic stem cell transplantation and review of the literature","volume":"11","author":"Henrich","year":"2009","journal-title":"Transplant Infect Dis"},{"key":"10.1016\/j.jinf.2011.11.002_bib6","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1128\/JCM.43.4.1818-1828.2005","article-title":"Invasive infections caused by Trichosporon species and Geotrichum capitatum in patients with hematological malignancies: a retrospective multicenter study from Italy and review of the literature","volume":"43","author":"Girmenia","year":"2005","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.jinf.2011.11.002_bib7","first-page":"785","article-title":"Saccharomyces cerevisiae fungemia with granulomas in the bone marrow in a patient undergoing BMT","volume":"15","author":"Cairoli","year":"1995","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jinf.2011.11.002_bib8","series-title":"Rhodotorula, Malassezia, Trichosporon and other yeast-like fungi. Clinical mycology","author":"Vazquez","year":"2003"},{"key":"10.1016\/j.jinf.2011.11.002_bib9","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/0732-8893(92)90118-D","article-title":"Yeast in blood cultures. Evaluation of factors influencing outcome","volume":"15","author":"Bryce","year":"1992","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.jinf.2011.11.002_bib10","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1086\/588660","volume":"46","author":"De Pauw","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jinf.2011.11.002_bib11","series-title":"Reference method for broth dilution antifungal susceptibility testing of yeasts; approved standard","author":"CLSI","year":"2008"},{"key":"10.1016\/j.jinf.2011.11.002_bib12","doi-asserted-by":"crossref","first-page":"2620","DOI":"10.1128\/JCM.00566-08","article-title":"Correlation of MIC with outcome for Candida species tested against caspofungin, anidulafungin, and micafungin: analysis and proposal for interpretive MIC breakpoints","volume":"46","author":"Pfaller","year":"2008","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.jinf.2011.11.002_bib13","series-title":"Manual of clinical microbiology","article-title":"Candida, Cryptococcus and other yeasts of medical importance","author":"Hazen","year":"2007"},{"key":"10.1016\/j.jinf.2011.11.002_bib14","series-title":"Medically important fungi: a guide to identification","author":"Larone","year":"2002"},{"key":"10.1016\/j.jinf.2011.11.002_bib15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1086\/599376","article-title":"Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 update by the Infectious Diseases Society of America","volume":"49","author":"Mermel","year":"2009","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jinf.2011.11.002_bib16","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1093\/clinids\/20.3.598","article-title":"Aspergillus fungemia: report of two cases and review","volume":"20","author":"Duthie","year":"1995","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jinf.2011.11.002_bib17","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1111\/j.1469-0691.2004.00933.x","article-title":"The significance of blood cultures positive for emerging saprophytic moulds in cancer patients","volume":"10","author":"Lionakis","year":"2004","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.jinf.2011.11.002_bib18","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1086\/590566","article-title":"Defining responses to therapy and study outcomes in clinical trials of invasive fungal diseases: mycoses study group and European organization for research and treatment of cancer consensus criteria","volume":"47","author":"Segal","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jinf.2011.11.002_bib19","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1097\/01.md.0000091182.93122.8e","article-title":"Candidemia in a tertiary care cancer center: in\u00a0vitro susceptibility and its association with outcome of initial antifungal therapy","volume":"82","author":"Antoniadou","year":"2003","journal-title":"Medicine"},{"key":"10.1016\/j.jinf.2011.11.002_bib20","first-page":"49","article-title":"Rhodotorula species fungemia: a threat to the immunocompromised host","volume":"49","author":"Anatoliotaki","year":"2003","journal-title":"Clin Lab"},{"key":"10.1016\/j.jinf.2011.11.002_bib21","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1093\/clinids\/14.4.841","article-title":"Sepsis due to Rhodotorula related to use of indwelling central venous catheters","volume":"14","author":"Kiehn","year":"1992","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jinf.2011.11.002_bib22","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1080\/13693780701381289","article-title":"Central venous catheter-associated fungemia due to Rhodotorula spp. \u2013 a systematic review","volume":"45","author":"Tuon","year":"2007","journal-title":"Med Mycol"},{"key":"10.1016\/j.jinf.2011.11.002_bib23","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1128\/JCM.01747-08","article-title":"Results from the ARTEMIS DISK global antifungal surveillance study, 1997 to 2007: an 10.5-year analysis of susceptibilities of Non-Candida yeast species to fluconazole and voriconazole determined by CLSI standardized disk diffusion testing","volume":"47","author":"Pfaller","year":"2009","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.jinf.2011.11.002_bib24","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1038\/sj.jim.7000318","article-title":"Binary and mixed population biofilms: time-lapse image analysis and disinfection with biocides","volume":"29","author":"Elvers","year":"2002","journal-title":"J Ind Microbiol Biotechnol"},{"key":"10.1016\/j.jinf.2011.11.002_bib25","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1086\/429916","article-title":"Saccharomyces cerevisiae fungemia: an emerging infectious disease","volume":"40","author":"Munoz","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jinf.2011.11.002_bib26","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1007\/s15010-007-6278-6","article-title":"Breakthrough Trichosporon asahii fungemia in neutropenic patient with acute leukemia while receiving caspofungin","volume":"36","author":"Bayramoglu","year":"2008","journal-title":"Infection"},{"key":"10.1016\/j.jinf.2011.11.002_bib27","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1128\/JCM.43.1.476-478.2005","article-title":"Activities of available and investigational antifungal agents against Rhodotorula species","volume":"43","author":"Diekema","year":"2005","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.jinf.2011.11.002_bib28","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1086\/507036","article-title":"Epidemiology and outcome of Rhodotorula fungemia in a tertiary care hospital","volume":"43","author":"Lunardi","year":"2006","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jinf.2011.11.002_bib29","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1097\/00005792-198607000-00005","article-title":"Trichosporonosis in patients with neoplastic disease","volume":"65","author":"Walsh","year":"1986","journal-title":"Medicine"},{"key":"10.1016\/j.jinf.2011.11.002_bib30","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1128\/JCM.41.2.911.2003","article-title":"Multidrug-resistant Trichosporon asahii isolates are susceptible to voriconazole","volume":"41","author":"Falk","year":"2003","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.jinf.2011.11.002_bib31","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1179\/joc.1996.8.6.445","article-title":"In\u00a0vitro susceptibility of Trichosporon beigelii to antifungal agents","volume":"8","author":"Perparim","year":"1996","journal-title":"J Chemother"},{"key":"10.1016\/j.jinf.2011.11.002_bib32","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1128\/jcm.28.7.1616-1622.1990","article-title":"Trichosporon beigelii, an emerging pathogen resistant to amphotericin B","volume":"28","author":"Walsh","year":"1990","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.jinf.2011.11.002_bib33","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1093\/clind\/15.5.781","article-title":"Azole therapy for trichosporonosis: clinical evaluation of eight patients, experimental therapy for murine infection, and review","volume":"15","author":"Anaissie","year":"1992","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jinf.2011.11.002_bib34","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1128\/AAC.46.4.1144-1146.2002","article-title":"In\u00a0vitro antifungal susceptibilities of Trichosporon species","volume":"46","author":"Paphitou","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jinf.2011.11.002_bib35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/10408410903241444","article-title":"Epidemiology of invasive mycoses in North America","volume":"36","author":"Pfaller","year":"2010","journal-title":"Crit Rev Microbiol"},{"key":"10.1016\/j.jinf.2011.11.002_bib36","doi-asserted-by":"crossref","first-page":"4745","DOI":"10.1002\/cncr.24507","article-title":"Candidemia in patients with hematologic malignancies in the era of new antifungal agents (2001-2007): stable incidence but changing epidemiology of a still frequently lethal infection","volume":"115","author":"Sipsas","year":"2009","journal-title":"Cancer"}],"container-title":["Journal of Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163445311005494?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163445311005494?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T21:16:01Z","timestamp":1759007761000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163445311005494"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,1]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,1]]}},"alternative-id":["S0163445311005494"],"URL":"https:\/\/doi.org\/10.1016\/j.jinf.2011.11.002","relation":{},"ISSN":["0163-4453"],"issn-type":[{"value":"0163-4453","type":"print"}],"subject":[],"published":{"date-parts":[[2012,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Rare opportunistic (non-Candida, non-Cryptococcus) yeast bloodstream infections in patients with cancer","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jinf.2011.11.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 The British Infection Association. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}